today is immune system hard-reboot day -6 (Autologous HSCT)
June 3, 2026 at 6:21 AM
today is immune system hard-reboot day -6 (Autologous HSCT)
Not that we need it per se, but a little bit more evidence that IL-6 can drive pathological inflammation in lungs...
(here in mouse model of post allo-HSCT)
@jidjournal.bsky.social
#immunosky #medsky
(here in mouse model of post allo-HSCT)
@jidjournal.bsky.social
#immunosky #medsky
Interleukin-6 is significantly increased in severe pneumonia after allo-HSCT and might induce lung injury via IL-6/sIL-6R/JAK1/STAT3 pathway
Interleukin-6 elevated in severe pneumonia after allo-HSCT and plays a role in lung injury via the IL-6/sIL-6R/JAK1/STAT3 pathway.
academic.oup.com
January 23, 2025 at 11:25 PM
Not that we need it per se, but a little bit more evidence that IL-6 can drive pathological inflammation in lungs...
(here in mouse model of post allo-HSCT)
@jidjournal.bsky.social
#immunosky #medsky
(here in mouse model of post allo-HSCT)
@jidjournal.bsky.social
#immunosky #medsky
Insightful session at EBMT 2026: Dr. Jon Salmanton-García @salmantongarcia.bsky.social presenting on rare fungal infections after HSCT (Fusarium, Scedosporium). Important perspectives on managing complex infections in immunocompromised patients. #EBMT2026 #HSCT #InfectiousDiseases
March 24, 2026 at 6:01 PM
Insightful session at EBMT 2026: Dr. Jon Salmanton-García @salmantongarcia.bsky.social presenting on rare fungal infections after HSCT (Fusarium, Scedosporium). Important perspectives on managing complex infections in immunocompromised patients. #EBMT2026 #HSCT #InfectiousDiseases
Post Edited: HSCT protecting against nerve loss https://multiple-sclerosis-research.org/2026/10/hsct-protecting-against-nerve-loss/
October 2, 2026 at 5:37 PM
Post Edited: HSCT protecting against nerve loss https://multiple-sclerosis-research.org/2026/10/hsct-protecting-against-nerve-loss/
HSCT improved the survival of adult EBV-HLH significantly. For patients who achieved PR after initial treatment, HSCT was recommended.
For patients who achieved PR after initial treatment, HSCT was recommended.
Interesting poster from ASH publications. #TxID #Idonc
Transplantation in adult patients with Epstein-Barr virus–associated hemophagocytic lymphohistiocytosis: yes or no?
Key PointsHSCT is recommended for patients achieving PR after initial treatment; patients with CR could adopt a wait-and-see strategy.Prognostic risk model
ashpublications.org
November 17, 2024 at 12:49 AM
Now on PubMed:
Improved outcome of HSCT in STAT1 gain-of-function disease following JAK inhibition bridging url: rupress.org/jhi/article/...
Improved outcome of HSCT in STAT1 gain-of-function disease following JAK inhibition bridging url: rupress.org/jhi/article/...
Improved outcome of HSCT in STAT1 gain-of-function disease following JAK inhibition bridging | Journal of Human Immunity | Rockefeller University Press
STAT1-GOF disease is characterized by infections and autoimmunity. In this article, overall survival after allogeneic HSCT in an international cohort of 36
rupress.org
October 31, 2025 at 2:54 AM
Now on PubMed:
Improved outcome of HSCT in STAT1 gain-of-function disease following JAK inhibition bridging url: rupress.org/jhi/article/...
Improved outcome of HSCT in STAT1 gain-of-function disease following JAK inhibition bridging url: rupress.org/jhi/article/...
I have MS & heard about MS being cured in other countries with patient stem cells www.mssociety.org.uk/living-with-...
10 yrs ago, I asked my neurologist. He said he was aware of it, but without FDA approval, the treatment is not offered.
Is Big Pharma blocking potential stem cell cures because 💸?
10 yrs ago, I asked my neurologist. He said he was aware of it, but without FDA approval, the treatment is not offered.
Is Big Pharma blocking potential stem cell cures because 💸?
February 15, 2025 at 8:20 PM
I have MS & heard about MS being cured in other countries with patient stem cells www.mssociety.org.uk/living-with-...
10 yrs ago, I asked my neurologist. He said he was aware of it, but without FDA approval, the treatment is not offered.
Is Big Pharma blocking potential stem cell cures because 💸?
10 yrs ago, I asked my neurologist. He said he was aware of it, but without FDA approval, the treatment is not offered.
Is Big Pharma blocking potential stem cell cures because 💸?
Long-term HIV remission has been achieved in a patient following a stem cell transplant from a sibling carrying a certain genetic mutation, according to research in Nature Microbiology. go.nature.com/4dLAj2L #medsky 🧪
April 13, 2026 at 7:10 PM
Long-term HIV remission has been achieved in a patient following a stem cell transplant from a sibling carrying a certain genetic mutation, according to research in Nature Microbiology. go.nature.com/4dLAj2L #medsky 🧪
Long-term HIV remission has been achieved in a patient following a stem cell transplant from a sibling carrying a certain genetic mutation, according to research in Nature Microbiology. go.nature.com/4dLAj2L #medsky 🧪
April 22, 2026 at 1:03 AM
Long-term HIV remission has been achieved in a patient following a stem cell transplant from a sibling carrying a certain genetic mutation, according to research in Nature Microbiology. go.nature.com/4dLAj2L #medsky 🧪
📢 Webinar: Antifungal prophylaxis & stewardship in HSCT
🗓️ May 12, 2025 | 13:00–14:00 CEST
🔍 Insights from an international survey on AF use in hematology & transplant units.
💬 Join the discussion!
🔗 Register: uni-koeln.zoom.us/meeting/regi...
#InfectiousDiseases #HSCT #AntifungalStewardship
🗓️ May 12, 2025 | 13:00–14:00 CEST
🔍 Insights from an international survey on AF use in hematology & transplant units.
💬 Join the discussion!
🔗 Register: uni-koeln.zoom.us/meeting/regi...
#InfectiousDiseases #HSCT #AntifungalStewardship
April 16, 2025 at 7:37 AM
📢 Webinar: Antifungal prophylaxis & stewardship in HSCT
🗓️ May 12, 2025 | 13:00–14:00 CEST
🔍 Insights from an international survey on AF use in hematology & transplant units.
💬 Join the discussion!
🔗 Register: uni-koeln.zoom.us/meeting/regi...
#InfectiousDiseases #HSCT #AntifungalStewardship
🗓️ May 12, 2025 | 13:00–14:00 CEST
🔍 Insights from an international survey on AF use in hematology & transplant units.
💬 Join the discussion!
🔗 Register: uni-koeln.zoom.us/meeting/regi...
#InfectiousDiseases #HSCT #AntifungalStewardship
📽️ Missed our webinar on Antifungal Prophylaxis and Stewardship in HSCT? Catch the recording now! Learn about global AF practices and stewardship in hematology & transplant care.
▶️ Watch here: youtu.be/-e8iZnF3x6I
#HSCT #InfectiousDiseases #AntifungalStewardship
▶️ Watch here: youtu.be/-e8iZnF3x6I
#HSCT #InfectiousDiseases #AntifungalStewardship
Antifungal Prophylaxis and Stewardship in HSCT
YouTube video by IDIM Infectious Diseases in Motion
youtu.be
May 13, 2025 at 9:13 AM
📽️ Missed our webinar on Antifungal Prophylaxis and Stewardship in HSCT? Catch the recording now! Learn about global AF practices and stewardship in hematology & transplant care.
▶️ Watch here: youtu.be/-e8iZnF3x6I
#HSCT #InfectiousDiseases #AntifungalStewardship
▶️ Watch here: youtu.be/-e8iZnF3x6I
#HSCT #InfectiousDiseases #AntifungalStewardship
First reported case of paracoccidioidomycosis after HSCT in a patient with chronic GVHD 🧬🦠🍄
Rare, but clinically relevant in endemic settings — keep it on the radar 🌎
Presented at ESCMID Global 2026 🇩🇪
#ESCMIDGlobal2026 #HSCT #InfectiousDiseases #Mycology
Rare, but clinically relevant in endemic settings — keep it on the radar 🌎
Presented at ESCMID Global 2026 🇩🇪
#ESCMIDGlobal2026 #HSCT #InfectiousDiseases #Mycology
April 25, 2026 at 8:56 PM
First reported case of paracoccidioidomycosis after HSCT in a patient with chronic GVHD 🧬🦠🍄
Rare, but clinically relevant in endemic settings — keep it on the radar 🌎
Presented at ESCMID Global 2026 🇩🇪
#ESCMIDGlobal2026 #HSCT #InfectiousDiseases #Mycology
Rare, but clinically relevant in endemic settings — keep it on the radar 🌎
Presented at ESCMID Global 2026 🇩🇪
#ESCMIDGlobal2026 #HSCT #InfectiousDiseases #Mycology
Our auto stem cell ward has only just returned to N95 masks. I think allo HSCT ward might not have stopped. Chemo day unit: no masks required. Once clinics: No masks. Haem clinics: masks required but most HCWs don't bother and no one checks to ensure they're following guidelines.
July 20, 2025 at 8:21 AM
Our auto stem cell ward has only just returned to N95 masks. I think allo HSCT ward might not have stopped. Chemo day unit: no masks required. Once clinics: No masks. Haem clinics: masks required but most HCWs don't bother and no one checks to ensure they're following guidelines.
Excited to share our new publication identifying unique features of CD56bright NK cells in HSCT recipients. Here we explore unique features of CD56bright NK cells in HSCT recipients protected from GVHD, and identify factors that shape their functions: www.cell.com/iscience/ful...
Single cell profiling of hematopoietic stem cell transplant recipients reveals TGF-β1 and IL-2 confer immunoregulatory functions to NK cells
NK cells exhibit diverse functions shaped by cytokines and microenvironments. We identify TGF-β1highCD56bright NK cells linked to protection from GVHT post-HSCT. IL-2 and TGF-β1 drive NK cells to a transient regulatory phenotype with unique transcriptional profiles, highlighting non-canonical regulatory functions can be induced by these cytokines.
www.cell.com
December 12, 2024 at 3:08 AM
Excited to share our new publication identifying unique features of CD56bright NK cells in HSCT recipients. Here we explore unique features of CD56bright NK cells in HSCT recipients protected from GVHD, and identify factors that shape their functions: www.cell.com/iscience/ful...
Swamy, Gray, Tangye et al. describe an Australian/New Zealand cohort where identification of monogenic #InbornErrorsOfImmunity through next-generation sequencing resulted in management change in 84% of cases including guiding #HSCT and initiating targeted treatment. rupress.org/jhi/article/...
October 1, 2026 at 4:00 PM
Swamy, Gray, Tangye et al. describe an Australian/New Zealand cohort where identification of monogenic #InbornErrorsOfImmunity through next-generation sequencing resulted in management change in 84% of cases including guiding #HSCT and initiating targeted treatment. rupress.org/jhi/article/...
Can we safely proceed with HSCT after COVID-19? 🤔🧬
Our new study says yes ✅ — overall survival is unchanged.
But ⚠️ the risk of acute GVHD is significantly higher in patients with prior COVID-19 😷➡️🧫
📄 Read more: doi.org/10.1038/s414...
#HSCT #COVID19 #GVHD #InfectiousDiseases #BMT #IDSky #TxID
Our new study says yes ✅ — overall survival is unchanged.
But ⚠️ the risk of acute GVHD is significantly higher in patients with prior COVID-19 😷➡️🧫
📄 Read more: doi.org/10.1038/s414...
#HSCT #COVID19 #GVHD #InfectiousDiseases #BMT #IDSky #TxID
May 25, 2025 at 9:10 PM
Can we safely proceed with HSCT after COVID-19? 🤔🧬
Our new study says yes ✅ — overall survival is unchanged.
But ⚠️ the risk of acute GVHD is significantly higher in patients with prior COVID-19 😷➡️🧫
📄 Read more: doi.org/10.1038/s414...
#HSCT #COVID19 #GVHD #InfectiousDiseases #BMT #IDSky #TxID
Our new study says yes ✅ — overall survival is unchanged.
But ⚠️ the risk of acute GVHD is significantly higher in patients with prior COVID-19 😷➡️🧫
📄 Read more: doi.org/10.1038/s414...
#HSCT #COVID19 #GVHD #InfectiousDiseases #BMT #IDSky #TxID
🟢 Les syndicats #SUDRail sont réunis deux jours en Conseil Fédéral.
➡️ Actualités #revendicatives
➡️ Priorités #syndicales 2025
➡️ Développement/syndicalisation
➡️ SUD-Rail dans @solidaires.org
➡️ Dossiers juridiques
➡️ Campagne HSCT
➡️ Actualités #revendicatives
➡️ Priorités #syndicales 2025
➡️ Développement/syndicalisation
➡️ SUD-Rail dans @solidaires.org
➡️ Dossiers juridiques
➡️ Campagne HSCT
February 4, 2025 at 10:31 AM
🟢 Les syndicats #SUDRail sont réunis deux jours en Conseil Fédéral.
➡️ Actualités #revendicatives
➡️ Priorités #syndicales 2025
➡️ Développement/syndicalisation
➡️ SUD-Rail dans @solidaires.org
➡️ Dossiers juridiques
➡️ Campagne HSCT
➡️ Actualités #revendicatives
➡️ Priorités #syndicales 2025
➡️ Développement/syndicalisation
➡️ SUD-Rail dans @solidaires.org
➡️ Dossiers juridiques
➡️ Campagne HSCT
On this #WorldAIDSday @cgaebler.bsky.social, Olaf Penack & teams at #CharitéBerlin report the #SecondBerlinPatient cured of #HIV after heterozygous CCR5Δ32 HSCT. The study opens exciting perspectives for immune-based #HIVCure strategies for longterm ART-free viral control and ultimately cure.
Sustained HIV-1 remission after heterozygous CCR5Δ32 stem cell transplantation - Nature
Nature - Sustained HIV-1 remission after heterozygous CCR5Δ32 stem cell transplantation
www.nature.com
December 1, 2025 at 9:48 PM
On this #WorldAIDSday @cgaebler.bsky.social, Olaf Penack & teams at #CharitéBerlin report the #SecondBerlinPatient cured of #HIV after heterozygous CCR5Δ32 HSCT. The study opens exciting perspectives for immune-based #HIVCure strategies for longterm ART-free viral control and ultimately cure.
🚨 Preliminary results! 🚨 Our systematic review & meta-analysis on stopping quinolone prophylaxis pre-engraftment in HSCT — just presented at the XXIV Brazilian Congress of Infectious Diseases.
#HSCT 🧬
#InfectiousDiseases 🌍 #BMT 💉 #IDSky 🌌 #TxID
#HSCT 🧬
#InfectiousDiseases 🌍 #BMT 💉 #IDSky 🌌 #TxID
September 18, 2025 at 6:35 PM
🚨 Preliminary results! 🚨 Our systematic review & meta-analysis on stopping quinolone prophylaxis pre-engraftment in HSCT — just presented at the XXIV Brazilian Congress of Infectious Diseases.
#HSCT 🧬
#InfectiousDiseases 🌍 #BMT 💉 #IDSky 🌌 #TxID
#HSCT 🧬
#InfectiousDiseases 🌍 #BMT 💉 #IDSky 🌌 #TxID
Do you focus on HSCT/Oncology ID? Want to be part of the editorial team of @thetxidjournal.bsky.social? Please apply by October 17 for an open position as outlined in this link!
@thetxidjournal.bsky.social is seeking applications for those interested in joining the editorial team (onlinelibrary.wiley.com/page/journal...) as an Associate Editor. We are specifically seeking someone who has clinical and research experience focused on HSCT/Oncology ID for this position.
1/4
1/4
Transplant Infectious Disease Editorial Board
Michael G. Ison MD, MS, Washington, DC, USA
onlinelibrary.wiley.com
September 26, 2025 at 6:52 PM
Do you focus on HSCT/Oncology ID? Want to be part of the editorial team of @thetxidjournal.bsky.social? Please apply by October 17 for an open position as outlined in this link!
Cut to the chase: Inpatient #palliativecare intervention led to substantial improvements in patients’ QOL, depression and PTSD symptoms, as well as caregiver anxiety during HSCT hospitalization with sustained effects on patients’ PTSD symptoms up to six months post-HSCT. #hapc24 #HemeOnc #MedSky
March 23, 2024 at 4:17 PM
Cut to the chase: Inpatient #palliativecare intervention led to substantial improvements in patients’ QOL, depression and PTSD symptoms, as well as caregiver anxiety during HSCT hospitalization with sustained effects on patients’ PTSD symptoms up to six months post-HSCT. #hapc24 #HemeOnc #MedSky
Frankfurt bound shot of the Howe Sound Crest trail (HSCT) as a reminder to finally hike it when I'm back!
July 5, 2025 at 11:21 AM
Frankfurt bound shot of the Howe Sound Crest trail (HSCT) as a reminder to finally hike it when I'm back!
In a groundbreaking study (NCT01087294), donor-derived CD19-CAR TSCM cells showed superior expansion & persistence vs. standard CAR T cells, achieving 100% response at low doses post-allogeneic HSCT! PMID:42066750, Cell 2026, @Cell https://www.cell.com/cell/fulltext/S0092-8674(26)00383-1 #Medsky 🧪
https://www.cell.com/cell/fulltext/S0092-8674(26)00383-1
No description available
www.cell.com
September 29, 2026 at 8:00 PM
In a groundbreaking study (NCT01087294), donor-derived CD19-CAR TSCM cells showed superior expansion & persistence vs. standard CAR T cells, achieving 100% response at low doses post-allogeneic HSCT! PMID:42066750, Cell 2026, @Cell https://www.cell.com/cell/fulltext/S0092-8674(26)00383-1 #Medsky 🧪
2) Cette étude a examiné l'impact du port obligatoire du masque FFP2 dans un service de soins pour patients ayant subi une greffe allogénique de cellules souches hématopoïétiques (allo-HSCT).
November 18, 2024 at 5:57 AM
2) Cette étude a examiné l'impact du port obligatoire du masque FFP2 dans un service de soins pour patients ayant subi une greffe allogénique de cellules souches hématopoïétiques (allo-HSCT).